About this conference
WCTPSCT is a 1-day conference in New York, USA on 8 Feb 2027. Abstract deadline: 7 Jan 2027. Fees: 30 - 400 USD. Organizer: iPHARMA Conferences.
Dedicated to the evolving science of selective cancer treatment, this conference addresses the role of tumor-activated prodrugs in optimizing therapeutic outcomes. The agenda features presentations on the latest techniques in drug design, targeting mechanisms in tumor environments, and advancements in clinical trials. Participants are invited to submit their original research studies for presentation, with a focus on novel prodrug candidates and their therapeutic implications. The program will also include expert panels discussing regulatory and ethical considerations in the use of engineered drugs. Networking opportunities are a key feature, allowing attendees to connect and explore collaborative possibilities. This multidisciplinary event seeks to highlight emerging trends and foster dialogue among oncology researchers, pharmacologists, and healthcare providers. Those interested in contributing to the knowledge base surrounding tumor-activated therapies should plan to register promptly.